Search Results 91-100 of 37278 for Two-phase

1. A Study of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with MCL-1 Dependence ≥ 40% - Mayo Clinic

   The purpose of this two-stage Phase 2 study is to assess the clinical response (Complete Remission) to FLAM compared to AM treatment in refractory or ...

2. Oncology (Medical) - Clinical trials

   The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as ...

3. Anaplastic large cell lymphoma - Stages - Mayo Clinic

   A stage 2 anaplastic large cell lymphoma involves two or more lymph node regions on the same side of the diaphragm. Stage 3 lymphoma. At stage 3 ...

4. Clinical trials - Oncology (Medical)

   This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

5. Phase 2 Nab®-Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects with Locally Advanced Pancreatic Cancer (LAPC) - Mayo Clinic

   This clinical study is in subjects who are 18 years old or older with locally advanced pancreatic cancer who have not received prior treatment for their ...

6. Oncology (Medical) - Clinical trials

   This phase II trial compares the impact of ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

7. Oncology (Medical) - Clinical trials

   The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II will ...

8. Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies - Mayo Clinic

   - To assess the pharmacodynamics (PD), immune response, and preliminary disease response. Phase 2 (stage 1): to evaluate the following objectives for Isatuximab ...

9. Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria - PHYOX 2 - Mayo Clinic

   Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous ...

10. Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer - Mayo Clinic

    Part A: (ADXS11-001 + MEDI4736 Combination Therapy) will determine the safety and tolerability of the combination and to identify a RP2D. Part B: Phase 2 design ...